18th Dec 2007 16:38
United Drug PLC18 December 2007 Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC 1. Identity of the issuer or the underlying issuer of existing shares towhich voting rights are attached: United Drug Plc 2. Reason for the notification (please tick the appropriate box orboxes): (u ) an acquisition or disposal of voting rights ( ) an acquisition or disposal of financial instruments which may resultin the acquisition of shares already issued to which voting rights are attached ( ) an event changing the breakdown of voting rights 3. Full name of person(s) subject to the notification obligation: FMRLLC and Fidelity International Limited and their direct subsidiaries 4. Full name of shareholder(s) (if different from 3.): 5. Date of the transaction and date on which the threshold is crossed orreached: 14 December 2007 6. Date on which issuer notified; 18 December 2007 7. Threshold(s) that is/are crossed or reached: 6% 8. Notified details:A) Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transaction(i)shares (if possible Triggering transactionusing the ISIN Number of Number of Number of shares Number of voting rights % of voting rightsCODE) Shares Voting rights Indirect Direct Indirect Direct IndirectIE0033024807 13,502,195 13,502,195 13,752,195 13,752,195 6.05 SUBTOTAL A (based 13,502,195 13,502,195 13,752,195 13,752,195 6.05on aggregate votingrights) B) Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Date Exercise/Conversion Number of voting % of voting instrument Period/ Date rights that may be rights acquired if the instrument is exercised/converted SUBTOTAL B (in relation to all expiration dates) Total (A+B) number of voting rights % of voting rights 13,752,195 6.05 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: 10. In case of proxy voting: FMR LLC and Fidelity International Limitedwill acquire to hold 250,000 voting rights as of 17 December 2007. 11. Additional information: Done at (place) on (date). FidelityIssuer name: United Drug Plc Current ownership percentage: 6.05% Total shares held: 13,752,195 Issued share capital: 227,163,819 SHARES HELD NOMINEE MANAGEMENT COMPANY Fidelity International Limited (FIL) is 4,577,250 BROWN BROTHERS HARRIMAN AND CO FMRCOthe parent holding company for various direct and 148,200 JP MORGAN CHASE BANK FMRCOindirect subsidiaries, including Fidelity Fund 8,818,945 STATE STREET BANK AND TR CO FMRCOManagement Limited (FFML), Fidelity Investment 207,800 BROWN BROS HARRIMN LTD LUX FILServices Ltd(FISL), Fidelity Gestion (FIGEST),FidelityInvestments Advisory (Korea) Limited(FIAKL),Fidelity Investments Management (HongKong)Limited (FIMHK), Fidelity PensionManagement(FPM), Fidelity Investments Japan (FIJ)and FidelityInvestments International (FII),investment managersfor various non-US investment companiesandinstitutional clients. FMR Corp is the parent holding company ofFidelityManagement & Research Company (FMRCO),investmentmanager for US mutual funds, and FidelityManagement TrustCompany (FMTC) and Pyramis GlobalAdvisors Trust Company(PGATC), a US state chartered bank whichacts as a trusteeor investment manager of various pensionand trust accountsand Pyramis Global Advisors LLC (PGALLC). Annex to the standard form TR-1 a) Identity of the person or legal entity subject to the notificationobligation:Full name (including legal form FMR LLC and Fidelity .....................................................................for legal entities) International Limited (FIL)Contact address (registered FMR LLC - 82 Devonshire .....................................................................office for legal entities) Street, Boston, MA, 02109 USA ..................................................................... FIL - Pembroke Hall, 42 Crow Lane, Pembroke, HM19 BermudaPhone number 44 (0) 1737 837 149 ....................................................................Other useful information (at Company Secretary ....................................................least legal representative forlegal persons) b) Identity of the notifier, if applicable:Full name FMR LLC and Fidelity ..................................................................... International Limited (FIL)Contact address Windmill Court XTW2B, ..................................................................... Millfield Lane, Lower Kingswood, Tadworth, Surrey ..................................................................... KT20 6RBPhone number 44 (0) 1737 837 149 .....................................................................Other useful information (e.g. Authorised to make this filingfunctional relationship with the under power of attorneyperson or legal entity subject tothe notification obligation) c) Additional information Please note that as a result of an internal merger reorganisation, FMR LLC isthe successor to FMR Corp. and has assumed all its rights and obligations. FMRLLC is a Delaware limited liability company with its principle place of businessat 82 Devonshire Street, Boston, Massachusetts, USA as stated above. This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange. -------------------------- (i) If the holding has fallen below the minimum threshold, thenotifying party should not be obliged to disclose the extent of the holding,only that the new holding is below 3%. For the case provided for in Article 10(a) of Directive 2004/109/EC, thereshould be no disclosure of individual holdings per party to the agreement unlessa party individually crosses or reaches an Article 9 threshold. This appliesupon entering into, introducing changes to or terminating an agreement. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
UDG.L